Three groups including Bain Capital and KKR are preparing to bid for Sapporo Holdings' real estate business, according to two ...

Bain Capital and KKR are among three groups preparing bids for Sapporo Holdings' real estate business, valued at approximately $2.7 billion. Sapporo is selling its real estate hol ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion.

Bain Capital Reportedly In Talks To Buy Mitsubishi Chemical's Pharma Unit For $3.2 Bln January 21, 2025 — 03:37 am EST Written by RTTNews.com for RTTNews -> ...

Bain Capital acquires Mitsubishi Tanabe Pharma for $3.3 billion, focusing on priority therapeutic areas including immunology, CNS, and diabetes.

Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to “accelerate the development and approval of innovative medicines in the ...

TOKYO (Reuters) -U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory ...